Stay updated on GB5121 in Refractory CNS Lymphoma Clinical Trial
Sign up to get notified when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.

Latest updates to the GB5121 in Refractory CNS Lymphoma Clinical Trial page
- Check2 days agoChange DetectedThe page now displays Revision: v3.6.3 in place of Revision: v3.6.2, indicating an update to the interface version. This is a UI/versioning change and does not alter the study data or its presentation beyond the version label.SummaryDifference0.1%

- Check9 days agoChange DetectedThe page now shows a new revision tag indicating v3.6.2, updating the page's version label. This reflects an internal update to the page template rather than changes to study data or content.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedRecruitment status is now shown as 'No longer looking for participants', indicating the study is not enrolling. The page also adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention label from 'Intervention / Treatment' to 'Intervention/Treatment' with a revision tag updated to v3.6.0.SummaryDifference0.5%

- Check31 days agoChange DetectedThe page shows a revision label updated from v3.5.4 to v3.5.5, indicating a newer page template version. This is a technical update and does not modify study details, eligibility criteria, results, or other substantive content.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a minor platform update. There are no changes to study content or user-facing features described on the page.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page revision updated from v3.5.2 to v3.5.3, signaling a new version of the page. This indicates a minor patch rather than any substantive changes to the study details.SummaryDifference0.1%

Stay in the know with updates to GB5121 in Refractory CNS Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.